Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Collet

Showing results (261-270 of 408) with videos related to

Pageof 41
Sort By:
Thrombosis and Haemostasis|January 12, 2010
Prasugrel compared with high-dose clopidogrel in acute coronary syndrome. The randomised, double-blind ACAPULCO studyGilles Montalescot, Georgios Sideris, Remy Cohen, et al.
Journal of the American College of Cardiology|April 25, 2015
Reply: Not All NSTEMIs Are Created EqualGilles Montalescot, Jean-Philippe Collet, Patrick Ecollan, et al.
Angiology|February 11, 2016
Intravenous Enoxaparin Versus Unfractionated Heparin in Elderly Patients Undergoing Primary Percutaneous Coronary Intervention: An Analysis of the Randomized ATOLL TrialZhenyu Liu, Johanne Silvain, Mathieu Kerneis, et al.
European Heart Journal. Cardiovascular Imaging|August 19, 2023
Phenotyping coronary plaque by computed tomography in premature coronary artery diseaseGhilas Rahoual, Michel Zeitouni, Etienne Charpentier, et al.
Journal of the American College of Cardiology|December 20, 2014
Effect of prasugrel pre-treatment strategy in patients undergoing percutaneous coronary intervention for NSTEMI: the ACCOAST-PCI studyGilles Montalescot, Jean-Philippe Collet, Patrick Ecollan, et al.
Thrombosis and Haemostasis|October 2, 2015
Point-of-care genetic profiling and/or platelet function testing in acute coronary syndromeJean-Philippe Collet, Mathieu Kerneis, Jean-Sébastien Hulot, et al.
International Journal of Cardiology|February 7, 2018
Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: The randomized AMERICA StudyJean-Philippe Collet, Guillaume Cayla, Pierre-Vladimir Ennezat, et al.
Journal of Thrombosis and Thrombolysis|June 9, 2009
Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent): a multicenter, open-label studyJoanna J Wykrzykowska, Ascan Warnholtz, Peter de Jaeger, et al.
The American Journal of Cardiology|December 14, 2004
Prognostic significance of renal insufficiency in patients presenting with acute coronary syndrome (the Prospective Multicenter SYCOMORE study)Raphaëlle Dumaine, Jean-Philippe Collet, Marie-Laure Tanguy, et al.
Acute Cardiac Care|March 25, 2014
Networks for improving care in patients with acute coronary syndrome: A frameworkPeter W Radke, Sigrun Halvorsen, J Wouter Jukema, et al.
Pageof 41

Showing results (261-270 of 408) with videos related to

Sort By:
Pageof 41
Thrombosis and Haemostasis|January 12, 2010
Prasugrel compared with high-dose clopidogrel in acute coronary syndrome. The randomised, double-blind ACAPULCO studyGilles Montalescot, Georgios Sideris, Remy Cohen, et al.
Journal of the American College of Cardiology|April 25, 2015
Reply: Not All NSTEMIs Are Created EqualGilles Montalescot, Jean-Philippe Collet, Patrick Ecollan, et al.
Angiology|February 11, 2016
Intravenous Enoxaparin Versus Unfractionated Heparin in Elderly Patients Undergoing Primary Percutaneous Coronary Intervention: An Analysis of the Randomized ATOLL TrialZhenyu Liu, Johanne Silvain, Mathieu Kerneis, et al.
European Heart Journal. Cardiovascular Imaging|August 19, 2023
Phenotyping coronary plaque by computed tomography in premature coronary artery diseaseGhilas Rahoual, Michel Zeitouni, Etienne Charpentier, et al.
Journal of the American College of Cardiology|December 20, 2014
Effect of prasugrel pre-treatment strategy in patients undergoing percutaneous coronary intervention for NSTEMI: the ACCOAST-PCI studyGilles Montalescot, Jean-Philippe Collet, Patrick Ecollan, et al.
Thrombosis and Haemostasis|October 2, 2015
Point-of-care genetic profiling and/or platelet function testing in acute coronary syndromeJean-Philippe Collet, Mathieu Kerneis, Jean-Sébastien Hulot, et al.
International Journal of Cardiology|February 7, 2018
Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: The randomized AMERICA StudyJean-Philippe Collet, Guillaume Cayla, Pierre-Vladimir Ennezat, et al.
Journal of Thrombosis and Thrombolysis|June 9, 2009
Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent): a multicenter, open-label studyJoanna J Wykrzykowska, Ascan Warnholtz, Peter de Jaeger, et al.
The American Journal of Cardiology|December 14, 2004
Prognostic significance of renal insufficiency in patients presenting with acute coronary syndrome (the Prospective Multicenter SYCOMORE study)Raphaëlle Dumaine, Jean-Philippe Collet, Marie-Laure Tanguy, et al.
Acute Cardiac Care|March 25, 2014
Networks for improving care in patients with acute coronary syndrome: A frameworkPeter W Radke, Sigrun Halvorsen, J Wouter Jukema, et al.
Pageof 41